Research

 

Home
Faculty
Clinical
Research
Education
Training
Publications
Information
Search

You Are Here: Home > Research

Research
Case Western Reserve University (CWRU) is one of the leading biomedical research institutions in the United States. The Infectious Diseases Research Institute (IDRI) at CWRU comprises 30 highly interactive faculty with research programs in the immunology, biochemistry, molecular biology, human genetics and epidemiology of infectious diseases. Fellows will participate in pathogen-oriented working groups, joint laboratory meetings, and seminars within the IDRI. There are opportunities for overseas research, and fellows will interact with the Center for AIDS Research, Tuberculosis Research Unit and AIDS Clinical Trials Unit (which are described below).

Areas of concentration include:

 
bulletMycobacterium tuberculosis
bullet HIV
bullet Antibiotic Resistance
bullet Malaria
bullet Helminth Infections
bulletBacterial Host Defense

[Back to Top]

 

Center For AIDS Research

 

The Center for AIDS Research (CFAR) at Case Western Reserve University (CWRU) was established in April 1994 as one of 11 such sites developed nationally by the National Institutes of Health. The CFAR has a mandate to coordinate basic research and clinical activities and to promote interdisciplinary research directed at HIV infection and AIDS. Together with other Centers on the CWRU campus, the CFAR will share responsibility for providing support facilities to the Cleveland scientific community throughout the coming decade.

CFAR membership includes scientist and clinicians from CWRU, University Hospitals of Cleveland and the research institute of the Cleveland Clinic Foundation (CCF). Current areas of research include: a) international aspects of AIDS; b) host-pathogen interactions; c) molecular and structural biology; d) clinical virology/mycology; e) behavioral research; and f) AIDS-related malignancies.

 

[Back to Top]

 

Tuberculosis Prevention and Control Research Unit

 

The Tuberculosis Prevention and Control Research Unit (TBRU) is a multi-disciplinary program involving 50 investigators at 7 domestic and 3 foreign institutions. The goal of the TBRU is to apply the latest advances in drug and vaccine development, microbiology and immunology in an integrated and coordinated fashion to the global problem of tuberculosis. The overall objectives of the TBRU are: 1) to evaluate modalities for prevention and treatment of TB through phase I/II clinical trials; 2) to characterized the current epidemiology of TB using molecular approaches; 3) to develop and validate microbiologic assays to monitor treatment, for the sensitive and rapid diagnosis of TB, and for rapid determination of drug susceptibility; and 4) to develop and validate immunologic markers of susceptibility/resistance.

 

[Back to Top]

 

AIDS Clinical Trials Unit

 

The AIDS Clinical Trials Unit (ACTU) at Case Western Reserve University (CWRU) has been in operation since 1987 and is a leader in clinical treatment trials and research for individuals with HIV infection. The ACTU is part of the national Adult AIDS Clinical Trials Group (AACTG). Faculty in the ACTU participate in design and implementation of new treatment protocols for HIV infection. Furthermore, faculty have access to all the newer and latest treatment options to control the HIV virus.

[Back to Top]

Antimicrobial Resistance Research

 

Infectious Disease Research & Teaching at the Veterans Affairs Medical Center

Wade Park, Cleveland, Ohio

The focus of research at the VA centers on the problems of antimicrobial resistance, bacterial pathogenesis, and mycobacteriology. This comprehensive program takes place at the Research Service of the Veterans Affairs Medical Center, Case Western Reserve University School of Medicine, and the Biomedical Research Building . Programs involve understanding the molecular genetics of ampicillin and vancomycin resistance in enterococci, the molecular epidemiolgy of vancomycin resistant enterococci and the relationship to antibiotic use, b-lactamase mediated resistance, host-pathogen interactions in mycobacteria and HIV infection, and prokaryotic cell-cell signaling.

Dr. Louis B. Rice. Chief of Medicine, Veterans Affairs Medical Center, Professor of Medicine, Case Western Reserve University, and member of the Infectious Diseases Section. The primary research interests of Dr. Rice involves understanding the molecular genetics of ampicillin and vancomycin resistance in Enterococcus faecium. His laboratory is dedicated to the characterization of mobile genetic elements in enterococci. Recent work centers upon determining the regulation and expression of resistant penicillin binding protein 5 (PBP5) in E. faecium. Other projects include: a) characterization of novel extended spectrum b-lactamase genes in Klebsiella pneumoniae and other enteric bacilli; b) testing the efficacy of antimicrobial agents in animal models of infection ; c) characterization of clinical isolates of methicillin resistant staphylococci.

Dr. Zara Toossi. Professor of Medicine Case Western Reserve University. Attending Physician, Infectious Disease Section, Veterans Affairs Medical Center. Dr. Toosi laboratory is interested in the host responses to mycobacteria. The laboratory studies the immunosuppressive effects of TGF-b, the interaction of cytokines and their net balance with regard to macrophage activation (or deactivation) and immune stimulation (or suppression). Her laboratory seeks to understand how these factors ultimately determine the success of host-immune response against tuberculosis . The lab investigates the interaction of transforming growth factor beta1 (TGF-b 1) and interleukin-10 (IL-10) in purified protein derivative (PPD)-stimulated human HIV infected mononuclear cell cultures in vitro.

Dr. Philip N. Rather. Associate Professor of Medicine Case Western Reserve University , member of the Division of Infectious Diseases and Molecular Biology and Microbiology. Dr. Rather studies the control of bacterial gene

expression by cell-to-cell communication with extracellular factors. His lab is interested in the mechanisms of cell to cell signaling (quorum sensing) in bacteria. Bacteria produce small chemical signals (pheromones or autoinducers) which regulate gene expression when they reach a critical concentration. The role of quorum sensing in regulation of a chromosomal 2'-N-acetyltransferase [aac(2')] in Providencia stuartii is one area of focus. His lab uses genetic approaches to dissect the regulatory pathways which control aac(2') expression. One pathway involves response to a small peptide signal, AR-factor, which represses aac(2') transcription. A second pathway involves regulation of mRNA stability. Another area of interest in the physiological role of quorum sensing in E. coli. A number of quorumsensing regulated genes have been identified and they appear to have a common role in amino acid cat abolism.

Dr. Curtis Donskey. Chief, Infection Control. Assistant Professor of Medicine, Case Western Reserve University. Attending Physician, Infectious Disease Section, Veterans Affairs Medical Center. Dr. Donskey's laboratory is interested in the molecular epidemiology of vancomycin-resistant enterococci (VRE). To this end his laboratory has established a mouse model of vancomycin-resistant Enterococcus faecium (VRE) intestinal colonization. This model is used to study the effect of different antibiotics on persistence and density of VRE colonization. His laboratory uses denaturing gradient gel electrophoresis to study the molecular epidemiolgy of pathogens that are difficult to isolate and culture. He is also developing a continuous flow culture system to investigate the interactions of intestinal pathogens in a dynamic system.

Dr. Richard Graham. Professor of Medicine, Case Western Reserve University. Attending Physician, Infectious Disease Section, Veterans Affairs Medical Center. Dr. Graham's academic interests include the clincal care of HIV infected patients. Major emphasis is also placed on teaching clinical infectious diseases syndromes.

Dr. Robert A. Bonomo. Section Chief, Veterans Affairs Medical Center. Dr. Bonomo's laboratory is dedicated to the study of structure function relationships in the class A b-lactamase, SHV. This chromosomal and plasmid encoded b-lactamase is usually found in Klebsiella pneumonia and confers high level resistance to third generation cephalosporins (cefotaxime, ceftazidime) and aztreonam. This resistance can render ineffective the most frequently used drugs to treat serious nosocomial infections. Our goals are to understand what amino acid substitutions permit evolution of novel substrate profiles and what factors control expression of these periplasmic enzymes. By using site directed mutagenesis and immunological tools to quantify expression, we are able to draw conclusions as to why these highly resistant variants may have arisen in nature. We are also interested in quantifying b-lactamase expression in organisms harboring Class C b-lactamases. We have developed antibodies able to detect the presence of this class of enzymes in clinical strains, thereby facilitating molecular epidemiological investigations

[Back to Top]

 

 

[Top] Home ] Faculty ] Clinical ] [ Research ] Education ] Training ] Publications ] Information ] Search ]

Case Western Reserve University, University Hospitals of Cleveland, and Veterans Administration Medical Center, Cleveland, Ohio